FCI
CRL icon

Financial Counselors Inc’s Charles River Laboratories CRL Stock Holding History

Financial Counselors Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,829
Closed -$2.83M – 118
2025
Q1 		$2.83M Sell
18,829
-16,884
-47% -$2.83M 0.04% 240
2024
Q4 		$6.59M Buy
35,713
+9,121
+34% +$1.76M 0.1% 174
2024
Q3 		$5.24M Buy
26,592
+4,896
+23% +$1.02M 0.08% 191
2024
Q2 		$4.48M Buy
21,696
+555
+3% +$126K 0.07% 195
2024
Q1 		$5.73M Sell
21,141
-19
-0.1% -$4.54K 0.1% 179
2023
Q4 		$5M Sell
21,160
-1,405
-6% -$276K 0.09% 182
2023
Q3 		$4.42M Buy
22,565
+992
+5% +$204K 0.09% 183
2023
Q2 		$4.54M Sell
21,573
-1,162
-5% -$231K 0.09% 180
2023
Q1 		$4.59M Sell
22,735
-3,624
-14% -$821K 0.1% 172
2022
Q4 		$5.74M Sell
26,359
-1,177
-4% -$257K 0.13% 159
2022
Q3 		$5.42M Buy
27,536
+2,986
+12% +$645K 0.13% 153
2022
Q2 		$5.25M Buy
24,550
+750
+3% +$183K 0.12% 162
2022
Q1 		$6.76M Buy
23,800
+1,462
+7% +$451K 0.14% 152
2021
Q4 		$8.42M Buy
22,338
+2,249
+11% +$874K 0.17% 145
2021
Q3 		$8.29M Sell
20,089
-2,222
-10% -$923K 0.18% 142
2021
Q2 		$8.25M Buy
22,311
+377
+2% +$126K 0.18% 142
2021
Q1 		$6.36M Buy
21,934
+4,309
+24% +$1.2M 0.15% 154
2020
Q4 		$4.4M Buy
17,625
+855
+5% +$204K 0.11% 177
2020
Q3 		$3.8M Buy
16,770
+697
+4% +$145K 0.11% 177
2020
Q2 		$2.8M Buy
16,073
+2,739
+21% +$437K 0.09% 200
2020
Q1 		$1.68M Buy
13,334
+5,245
+65% +$787K 0.07% 206
2019
Q4 		$1.24M Buy
8,089
+3,684
+84% +$510K 0.04% 261
2019
Q3 		$583K Buy
+4,405
New +$591K 0.02% 324

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Financial Counselors Inc's CRL Position: Q2 2025 in Review

Financial Counselors Inc sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 18,829 shares — an estimated $2.83M sold.

Financial Counselors Inc first reported a position in CRL in Q3 2019 and held it in 23 quarters. The position peaked at $8.42M in Q4 2021. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Financial Counselors Inc reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 18,829 Charles River Laboratories shares in Q2 2025, an estimated $2.83M.
  • Financial Counselors Inc first reported a position in Charles River Laboratories in Q3 2019 and held it in 23 quarters.
  • Financial Counselors Inc's Charles River Laboratories position peaked at $8.42M in Q4 2021.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.